Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients

BACKGROUND: HIV-infected patients on antiretroviral therapy frequently develop dyslipidemias and, despite therapy with potent lipid-lowering agents, a high percentage does not achieve guideline recommended lipid targets. In this study, we examined the efficacy of combination treatment with a statin...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeedi, Ramesh, Johns, Kevin, Frohlich, Jiri, Bennett, Matthew T., Bondy, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488121/
https://www.ncbi.nlm.nih.gov/pubmed/26087958
http://dx.doi.org/10.1186/s12944-015-0054-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488121/
https://www.ncbi.nlm.nih.gov/pubmed/26087958
http://dx.doi.org/10.1186/s12944-015-0054-x

Ejemplares similares